Search results
2 days ago · Janssen is a global biopharmaceutical company that develops and delivers innovative medicines to treat and prevent complex diseases. Learn more about Janssen's history, vision, values, and impact in over 150 countries.
- Careers
My colleagues are smart and value each other’s knowledge....
- Contact Us
Contact Janssen in the US or globally for corporate...
- Janssen United States
Explore the Janssen United States site, and see how we...
- Oncology
The Janssen Oncology team is working with intentional focus...
- About Us
At Janssen, we’re creating a future where disease is a thing...
- Our Company
Our Company - Pharmaceutical Companies of Johnson & Johnson...
- Careers
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Learn about Janssen, the Pharmaceutical Companies of Johnson & Johnson, and their focus on areas of medicine where they can make the biggest difference. Follow their updates, videos, and stories on LinkedIn.
Janssen is a leading pharmaceutical company that collaborates with the world to transform lives with life-saving and life-changing solutions. It focuses on six therapeutic areas and is named after Dr. Paul Janssen, a pioneer in pharmaceutical research.
Explore the Janssen United States site, and see how we collaborate with partners around the world to make patients healthier.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. FDA has authorized its single-dose COVID-19 vaccine for emergency use. The vaccine, developed by the AdVac ® platform, showed 85 percent efficacy in preventing severe disease and protection against hospitalization and death.
Mar 3, 2021 · Learn how Johnson & Johnson developed and produced its Janssen COVID-19 Vaccine in less than a year, with the help of global partners and existing technologies. See the steps from cell growth to vial filling and distribution.